A detailed history of Zega Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Zega Financial, LLC holds 3,387 shares of ABT stock, worth $386,897. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,387
Previous 3,398 0.32%
Holding current value
$386,897
Previous $353 Million 9.36%
% of portfolio
0.06%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $1,100 - $1,299
-11 Reduced 0.32%
3,387 $386 Million
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $342,280 - $382,071
3,398 New
3,398 $353 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $1.49 Million - $1.83 Million
16,571 New
16,571 $1.82 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Zega Financial, LLC Portfolio

Follow Zega Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zega Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zega Financial, LLC with notifications on news.